| Univariate |  | Multivariate |  |
---|---|---|---|---|
 | OR (95% CI) | P | OR (95% CI) | P |
IPVV (mL) | 0.99 (0.99–1.00) | 0.008 | 0.98 (0.97–0.99) |  < 0.001 |
Age (years) | 1.10 (1.05–1.16) |  < 0.001 | 1.12 (1.04–1.20) | 0.002 |
Female (%) | 0.98 (0.43–2.22) | 0.959 |  |  |
Disease duration (months) | 1.02 (0.96–1.07) | 0.567 |  |  |
Smoking history (years) | 2.68 (1.26–5.74) | 0.011 | 7.44 (2.30–24.05) |  < 0.001 |
BMI (kg/m^2) | 1.04 (0.89–1.22) | 0.650 |  |  |
FPG (mmol/L) | 1.23 (1.02–1.48) | 0.027 | 1.51 (1.11–2.05) | 0.009 |
HbA1c (mmol/mol) | 1.04 (1.01–1.07) | 0.022 | 1.04 (0.99–1.09) | 0.105 |
Baseline C-peptide levels (ng/mL) | 2.70 (1.14–6.38) | 0.024 |  |  |
Fasting insulin (uU/ml) | 0.93 (0.83–1.04) | 0.175 |  |  |
TG (mmol/L) | 0.76 (0.45–1.28) | 0.302 |  |  |
TC (mmol/L) | 0.86 (0.60–1.25) | 0.429 |  |  |
LDL-C (mmol/L) | 0.87 (0.56–1.36) | 0.545 |  |  |
HDL-C (mmol/L) | 0.61 (0.15–2.45) | 0.487 |  |  |
Hcy (umol/L) | 1.21 (1.02–1.43) | 0.027 |  |  |
SCr (umol/L) | 1.00 (0.99–1.01) | 0.523 |  |  |
SUA (umol/L) | 1.00 (0.99–1.00) | 0.201 |  |  |
SUA/SCr | 0.760 (0.533–1.084) | 0.130 |  |  |
Cys-C (mg/L) | 6.67 (1.09–40.77) | 0.04 | 3.79 (0.38–38.25) | 0.259 |
LDH (U/L) | 1.02 (1.00–1.03) | 0.018 | 1.01 (1.00–1.03) | 0.117 |
Use of insulin | 0.82 (0.37–1.83) | 0.625 |  |  |